Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
Phase 4
Terminated
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2021-05-17
- Lead Sponsor
- Rare Disease Research, LLC
- Target Recruit Count
- 2
- Registration Number
- NCT04708314
- Locations
- 🇺🇸
Rare Disease Research, LLC, Atlanta, Georgia, United States
🇺🇸Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
News
No news found